Maha Hussain

1995–2026 年に発表

152
論文数
41,640
被引用数
88
h 指数
142
i10 指数

被引用数

Maha Hussain の年別被引用数1896 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 3 件1999 年: 被引用 4 件2000 年: 被引用 16 件2001 年: 被引用 30 件2002 年: 被引用 29 件2003 年: 被引用 32 件2004 年: 被引用 54 件2005 年: 被引用 92 件2006 年: 被引用 96 件2007 年: 被引用 126 件2008 年: 被引用 126 件2009 年: 被引用 201 件2010 年: 被引用 180 件2011 年: 被引用 214 件2012 年: 被引用 173 件2013 年: 被引用 209 件2014 年: 被引用 242 件2015 年: 被引用 241 件2016 年: 被引用 346 件2017 年: 被引用 364 件2018 年: 被引用 397 件2019 年: 被引用 1,188 件2020 年: 被引用 1,416 件2021 年: 被引用 1,658 件2022 年: 被引用 1,306 件2023 年: 被引用 1,130 件2024 年: 被引用 1,878 件2025 年: 被引用 830 件2026 年: 被引用 24 件1897〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,327 件、この内訳の 27.7%イギリス: 引用元論文 1,166 件、この内訳の 7.5%中国: 引用元論文 1,092 件、この内訳の 7%カナダ: 引用元論文 844 件、この内訳の 5.4%イタリア: 引用元論文 825 件、この内訳の 5.3%ドイツ: 引用元論文 815 件、この内訳の 5.2%フランス: 引用元論文 634 件、この内訳の 4.1%オーストラリア: 引用元論文 535 件、この内訳の 3.4%スペイン: 引用元論文 535 件、この内訳の 3.4%日本: 引用元論文 503 件、この内訳の 3.2%オランダ: 引用元論文 419 件、この内訳の 2.7%スイス: 引用元論文 388 件、この内訳の 2.5%
0%27.7%その他 22.6%

分野

  • Medicine73.9%
  • Biochemistry, Genetics and Molecular Biology21.1%
  • Immunology and Microbiology1.8%
  • Materials Science0.5%
  • Mathematics0.3%
  • Chemistry0.2%
  • その他2.2%

トピック

  • Prostate Cancer Treatment and Research16.7%
  • Prostate Cancer Diagnosis and Treatment8.7%
  • Radiopharmaceutical Chemistry and Applications3.8%
  • Cancer Genomics and Diagnostics3.5%
  • PARP inhibition in cancer therapy3%
  • Cancer, Lipids, and Metabolism2.8%
  • その他61.5%

共著者

全論文

検索で開く
  1. Olaparib for Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 2,237

  2. Integrative Clinical Genomics of Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 被引用: 3,701

  3. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 2,835

  5. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 904

  6. ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 被引用: 629

  7. Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 766

  8. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liying Zhang, Ahmet Zehir, Joseph Vijai, Howard I. Scher, Charles L. Sawyers, Nikolaus Schultz, Philip W. Kantoff, David B. Solit, Mark E. Robson, Eliezer M. Van Allen, Kenneth Offit, Johann S. de Bono, Peter S. Nelson - New England Journal of Medicine 2016 被引用: 1,663

  9. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 1,106

  10. Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 186

  11. Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2021 被引用: 412

  12. Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , - New England Journal of Medicine 2018 被引用: 1,043

  13. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  14. Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

    著者: , , , , , , , , , , , , , - New England Journal of Medicine 2004 被引用: 3,687

  15. Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 2,241

  16. Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 215

  17. Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 被引用: 422

  18. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , - European Urology 2023 被引用: 131

  19. Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 463

  20. CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors

    著者: , , , , , , , , , , , , , , , , , , - JCO Precision Oncology 2020 被引用: 206

  21. Integrative Clinical Genomics of Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 被引用: 591

  22. Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 91

  23. Identification of Targetable FGFR Gene Fusions in Diverse Cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 被引用: 738

  24. Intermittent versus Continuous Androgen Deprivation in Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 568